Interaction Qualified Primary Hepatocytes | Lonza Product Overview
Advance your in vitro drug interaction studies to the next level! Watch this video to learn how our Interaction Qualified primary hepatocytes can increase your confidence in your DDI and metabolism studies.
Ketamine as an Antidepressant With Dr. Lisa Monteggia
The Monteggia laboratory at Vanderbilt University has been investigating the molecular mechanisms that underly this rapid action. In this Teach Me in 10, Dr. Monteggia outlines some of the key discoveries that her team have made, particularly in relation to ketamine, neuroplasticity and neuroreceptors.
Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis
In this talk, Martin Gijs discusses a novel magnetic surface coverage assay and a microfluidic tissue processor with applications in cancer diagnostics.
Detection and Expression Profiling of Tumor Initiating Cells (TIC) Among the Peripherally Circulating Epithelial Tumor Cells from Patients with Breast Cancer
Katharina Pachmann shows that among the peripherally circulating tumor cells a variable fraction is able to express stem cell and adhesion properties and can be grown into tumor spheres, a property ascribed to cells capable of initiating tumors and metastases.
Monitoring Dynamic Interactions of Tumor Cells with Tissue and Immune Cells in a Lab-on-a-Chip
Peter Ertl discusses how for the first time, direct cell-to-cell interactions of tumor cells with bead-activated primary T cells were continuously assessed using an effector cell to target cell ratio of 10:1.
Improvements in Molecular Diagnosis of Pathogens and Diseases
This talk offers a valuable guide to the development of LAMP in molecular detection and determination of target sequences and will present examples with bright field applications of the method from the detection of pathogens to clinical applications for the diagnosis of cancer and other disorders.
DNA Methylation and the Cancer Epigenome Biological and Translations Implications
In this talk, Stephen Baylin, discusses the development of strategies for “epigenetic therapies” for cancer and biomarker development.
The Isolation and Characterization of Brain Metastasis – Competent Breast Cancer CTCs
Dario Marchetti, Professor/Director, Baylor College of Medicine, speaking at CellTech 2013.
Regulation of antibody immunotherapy by fine-tuning FcR interactions
In this talk, Mark Cragg, presents evidence that different mAb's interact with Fc receptors differently in order to achieve their therapeutic activities.